Cardlytics Inc. (NASDAQ: CDLX) reported insider sales early in April 2026 as Chief Executive Officer Amit Gupta sold 116,774 shares of common stock across two trading days for about $118,425 in total proceeds. The transactions were executed on April 1 and April 2, 2026, at prices ranging from $0.965 to $1.085 per share, while the stock recently traded at $1.13 - a level that represents a 52% decline over the prior six months.
The disposition unfolded in two tranches: on April 1, Gupta sold 62,549 shares at a weighted average price of $0.99. The following day, April 2, he sold 54,225 shares at a weighted average price of $1.042. In a related move on the same day, Gupta exercised options to acquire 514,350 shares of Cardlytics common stock through the vesting of 514,350 Restricted Stock Units.
Separately, Cardlytics disclosed fourth-quarter results for fiscal year 2025 that were mixed. The company reported revenue of $56.1 million, beating the anticipated $55.17 million by roughly 1.69%. Reported earnings per share were -$0.28, which matched analysts' expectations.
In a corporate transaction tied to strategic asset reallocation, Cardlytics completed the sale of its Bridg platform assets to PAR Technology Corporation and received 1,810,222 shares of PAR Technology's common stock as consideration for the deal.
Analyst reaction has been notable. Evercore ISI reduced its price target on Cardlytics to $1 from $2 while maintaining an In Line rating, citing the end of a partnership with Bank of America and content restrictions at Chase as factors weighing on the company’s first-quarter outlook. BofA Securities also lowered its price target to $0.90 from $1.50 and kept an Underperform rating, referencing issues with two major financial institution partners.
The insider sales and analyst adjustments occur as the stock trades well below recent levels. InvestingPro analysis, referenced in company reporting, suggests Cardlytics may be undervalued at current prices and indicates that comprehensive metrics are available for further evaluation.
These disclosures and developments sketch an operational and market backdrop in which management-level stock sales, recent financial results, a strategic asset sale, and analyst reassessments intersect as Cardlytics navigates partnerships with major financial institutions.
Key points
- Amit Gupta sold 116,774 Cardlytics shares on April 1 and April 2, 2026, for roughly $118,425; prices ranged from $0.965 to $1.085 per share.
- Cardlytics reported Q4 fiscal 2025 revenue of $56.1 million - a 1.69% beat versus the expected $55.17 million - and EPS of -$0.28, in line with expectations.
- The sale of Bridg platform assets to PAR Technology closed with Cardlytics receiving 1,810,222 shares of PAR Technology common stock; analysts have cut price targets amid partner-related headwinds.
Risks and uncertainties
- Partner-related challenges - End of a Bank of America partnership and content restrictions at Chase have prompted analysts to reduce price targets, affecting Cardlytics' near-term outlook. This impacts the financial services and digital advertising sectors.
- Stock volatility and valuation - The stock's 52% decline over six months and active insider transactions introduce uncertainty for equity holders and potential investors in the fintech and marketing technology spaces.
- Analyst downgrades - Lowered price targets and maintained Underperform/In Line ratings by major brokerages add downward pressure on sentiment and could influence capital market access for the company.